Alx Oncology Holdings (ALXO) Tax Provisions (2019 - 2020)
Alx Oncology Holdings recorded quarterly Tax Provisions of $182000.0 in Q4 2020, up 420.0% quarter-over-quarter from $35000.0 in Q3 2020, and up 1922.22% year-over-year from $9000.0 in Q1 2020.
Alx Oncology Holdings' Tax Provisions history runs 2 years deep, the most recent figure standing at $182000.0 for Q4 2020.
- In Q4 2020, Tax Provisions rose 1922.22% year-over-year to $182000.0; the TTM figure through Dec 2020 stood at $241000.0 (changed N/A YoY), while the FY2022 annual figure was $64000.0, up 404.76% from the prior year.
- Tax Provisions came in at $182000.0 for Q4 2020 at Alx Oncology Holdings, up from $35000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $182000.0 in Q4 2020 to a low of $4000.0 in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 216,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Alx Oncology Holdings | 189.80 Mn | 49.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 182,000.00 |
| Sep 30, 2020 | 35,000.00 |
| Jun 30, 2020 | 20,000.00 |
| Mar 31, 2020 | 4,000.00 |
| Dec 31, 2019 | 9,000.00 |
| Sep 30, 2019 | 8,000.00 |
| Jun 30, 2019 | 8,000.00 |